Xinrong Luo

744 total citations
17 papers, 609 citations indexed

About

Xinrong Luo is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Xinrong Luo has authored 17 papers receiving a total of 609 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 5 papers in Oncology and 4 papers in Cancer Research. Recurrent topics in Xinrong Luo's work include Epigenetics and DNA Methylation (7 papers), Cancer-related gene regulation (7 papers) and Wnt/β-catenin signaling in development and cancer (3 papers). Xinrong Luo is often cited by papers focused on Epigenetics and DNA Methylation (7 papers), Cancer-related gene regulation (7 papers) and Wnt/β-catenin signaling in development and cancer (3 papers). Xinrong Luo collaborates with scholars based in China, Hong Kong and United States. Xinrong Luo's co-authors include Guosheng Ren, Tingxiu Xiang, Xuedong Yin, Lili Li, Hongyuan Li, Xiaoyi Wang, Qian Tao, Peng Li, Jinxiang Tan and Weiyan Peng and has published in prestigious journals such as PLoS ONE, The FASEB Journal and Cellular and Molecular Life Sciences.

In The Last Decade

Xinrong Luo

16 papers receiving 602 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xinrong Luo China 13 441 211 126 59 39 17 609
Miguel A. Mendoza‐Catalán Mexico 14 314 0.7× 190 0.9× 170 1.3× 50 0.8× 37 0.9× 35 616
Liying Wu China 13 323 0.7× 191 0.9× 102 0.8× 52 0.9× 18 0.5× 23 520
Xundi Xu China 13 424 1.0× 206 1.0× 130 1.0× 48 0.8× 23 0.6× 31 718
Cenk Kığ Türkiye 8 449 1.0× 136 0.6× 68 0.5× 46 0.8× 34 0.9× 16 649
Xianfang Liu China 13 427 1.0× 142 0.7× 87 0.7× 57 1.0× 42 1.1× 22 584
Qichao Xie China 12 424 1.0× 266 1.3× 121 1.0× 90 1.5× 15 0.4× 25 611
Chenglin Li China 13 379 0.9× 162 0.8× 62 0.5× 44 0.7× 56 1.4× 29 544
Mu-Xin Wei China 15 419 1.0× 143 0.7× 108 0.9× 48 0.8× 22 0.6× 34 641

Countries citing papers authored by Xinrong Luo

Since Specialization
Citations

This map shows the geographic impact of Xinrong Luo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xinrong Luo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xinrong Luo more than expected).

Fields of papers citing papers by Xinrong Luo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xinrong Luo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xinrong Luo. The network helps show where Xinrong Luo may publish in the future.

Co-authorship network of co-authors of Xinrong Luo

This figure shows the co-authorship network connecting the top 25 collaborators of Xinrong Luo. A scholar is included among the top collaborators of Xinrong Luo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xinrong Luo. Xinrong Luo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Bai, Jie, et al.. (2023). Capecitabine-based chemotherapy in early-stage triple-negative breast cancer: a meta-analysis. Frontiers in Oncology. 13. 1245650–1245650.
2.
Li, Li, Jun Tang, Lili Li, et al.. (2022). ZBTB28 inhibits breast cancer by activating IFNAR and dual blocking CD24 and CD47 to enhance macrophages phagocytosis. Cellular and Molecular Life Sciences. 79(2). 83–83. 20 indexed citations
3.
He, Mei, et al.. (2021). Mining immune-related genes with prognostic value in the tumor microenvironment of breast invasive ductal carcinoma. Medicine. 100(17). e25715–e25715. 2 indexed citations
4.
Cao, Yuan, et al.. (2020). LncRNA PART1 promotes lung squamous cell carcinoma progression via miR-185-5p/Six1 axis. Human & Experimental Toxicology. 40(6). 960–976. 12 indexed citations
5.
He, Qiang, Ling Zhang, Qing Shao, et al.. (2019). Dual inhibition of Akt and ERK signaling induces cell senescence in triple-negative breast cancer. Cancer Letters. 448. 94–104. 39 indexed citations
6.
Huang, Yujing, Qing Shao, Xinrong Luo, et al.. (2018). Poly(ADP‐ribose) polymerase‐1 promotes recruitment of meiotic recombination‐11 to chromatin and DNA double‐strand break repair in Ku70‐deficient breast cancer cells. The FASEB Journal. 32(11). 6112–6122. 7 indexed citations
7.
Li, Xia, Jianbo Huang, Xinrong Luo, et al.. (2018). Paired box 5 is a novel marker of breast cancers that is frequently downregulated by methylation. International Journal of Biological Sciences. 14(12). 1686–1695. 10 indexed citations
8.
Luo, Xinrong, Xin Xiong, Qing Shao, et al.. (2017). The tumor suppressor interferon regulatory factor 8 inhibits β-catenin signaling in breast cancers, but is frequently silenced by promoter methylation. Oncotarget. 8(30). 48875–48888. 26 indexed citations
9.
Shao, Qing, Xinrong Luo, Dejuan Yang, et al.. (2017). Phospholipase Cδ1 suppresses cell migration and invasion of breast cancer cells by modulating KIF3A-mediated ERK1/2/β- catenin/MMP7 signalling. Oncotarget. 8(17). 29056–29066. 26 indexed citations
10.
Yin, Xuedong, Tingxiu Xiang, Junhao Mu, et al.. (2016). Protocadherin 17 functions as a tumor suppressor suppressing Wnt/β-catenin signaling and cell metastasis and is frequently methylated in breast cancer. Oncotarget. 7(32). 51720–51732. 48 indexed citations
11.
Wang, Na, Lijuan Zhao, Shuman Li, et al.. (2015). Methylation of PLCD1 and adenovirus-mediated PLCD1 overexpression elicits a gene therapy effect on human breast cancer. Experimental Cell Research. 332(2). 179–189. 39 indexed citations
12.
Li, Chunhong, Liping Tang, Lijuan Zhao, et al.. (2015). OPCML is frequently methylated in human colorectal cancer and its restored expression reverses EMT via downregulation of smad signaling.. PubMed. 5(5). 1635–48. 30 indexed citations
13.
Xiao, Yun, Tingxiu Xiang, Xinrong Luo, et al.. (2014). Zinc-Finger Protein 545 Inhibits Cell Proliferation as a Tumor Suppressor through Inducing Apoptosis and is Disrupted by Promoter Methylation in Breast Cancer. PLoS ONE. 9(10). e110990–e110990. 26 indexed citations
14.
Shi, Yuan, Xinrong Luo, Peng Li, et al.. (2014). miR-7-5p suppresses cell proliferation and induces apoptosis of breast cancer cells mainly by targeting REGγ. Cancer Letters. 358(1). 27–36. 116 indexed citations
15.
16.
Yin, Xuedong, Xinrong Luo, Hongyuan Li, et al.. (2013). Livin promotes progression of breast cancer through induction of epithelial–mesenchymal transition and activation of AKT signaling. Cellular Signalling. 25(6). 1413–1422. 35 indexed citations
17.
Yin, Xuedong, Tingxiu Xiang, Lili Li, et al.. (2013). DACT1, an antagonist to Wnt/β-catenin signaling, suppresses tumor cell growth and is frequently silenced in breast cancer. Breast Cancer Research. 15(2). R23–R23. 79 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Miguel A. Mendoza‐Catalán Breakdown of academic impact, for papers by Liying Wu Breakdown of academic impact, for papers by Xundi Xu Breakdown of academic impact, for papers by Cenk Kığ Breakdown of academic impact, for papers by Xianfang Liu Breakdown of academic impact, for papers by Qichao Xie Breakdown of academic impact, for papers by Chenglin Li Breakdown of academic impact, for papers by Mu-Xin Wei
Rankless by CCL
2026